All ETDs from UAB

Advisory Committee Chair

Xu Feng

Advisory Committee Members

Scott W Ballinger

Amjad Javed

Jay M McDonald

John M Mountz

Document Type

Dissertation

Date of Award

2010

Degree Name by School

Doctor of Philosophy (PhD) Heersink School of Medicine

Abstract

The receptor activator of NF-қB (RANK) ligand (RANKL) and its receptor RANK play a critical role in osteoclast biology. RANK has three tumor necrosis factor receptor associated factor (TRAF)-binding motifs [PFQEP369-373 (Motif 1), PVQEET559-564 (Motif 2), and PVQEQG604-609 (Motif 3)] that regulate osteoclast formation and function. RANK also contains a TRAF-independent motif (IVVY535-538) that commits bone marrow macrophages (BMMs), which are osteoclast precursors, to the osteoclast lineage for osteoclastogenesis. Notably, tumor necrosis factor-α (TNF) and interlukin-1 (IL-1) utilize TRAFs to initiate most of the signaling pathways known to be activated by RANKL but fail to form osteoclasts unless attended by permissive levels of RANKL, suggesting that TNF- and IL-1-mediated osteoclastogenesis may require priming of BMMs by RANKL. Moreover, unlike RANK, TNF and IL-1 receptors lack the IVVY motif, which may explain the inability of TNF or IL-1 alone to stimulate osteoclastogenesis. Herein, I sought to determine the molecular mechanism underlying the RANKL requirement for TNF- and IL-1-mediated osteoclast formation and function by using a chimeric-receptor approach. In the first and second parts of my thesis, I addressed the role of the RANK IVVY motif in TNF- and IL-1-mediated osteoclastogenesis, respectively. I then determined the role of Motif 1/Motif 2/Motif 3 of RANK in TNF- and IL-1-mediated osteoclast formation and function. The results indicate that TNF- and IL-1-mediated osteoclastogenesis requires RANK signaling from IVVY motif, Motif 2 and Motif 3. Significantly, my thesis work has established that the RANK IVVY535-538, PVQEET559-564, and PVQEQG604-609 motifs may serve as attractive therapeutic targets for bone loss accompanying many bone disorders.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.